Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 1;18(Suppl 2):s66-s69.
doi: 10.7861/clinmedicine.18-2-s66.

Surveillance for hepatocellular cancer

Anna Roskilly  1 , Ian A Rowe  2
Affiliations
Review

Surveillance for hepatocellular cancer

Anna Roskilly et al. Clin Med (Lond). .

Abstract

Hepatocellular carcinoma (HCC) is a common complication of cirrhosis. The incidence of HCC is rising and HCC-related mortality is rising in parallel such that there were more than 1,700 deaths in the UK in 2015. Since cirrhosis is a known risk factor for the development of HCC and early diagnosis is associated with improved outcomes, surveillance for the development of HCC using regular ultrasound scans is recommended by many expert bodies including the National Institute for Health and Care Excellence (NICE). This surveillance is not supported by high-quality evidence and there is an increasing appreciation of the associated harms. In this review the likely benefits of surveillance are discussed together with recommendations to increase the effectiveness of surveillance overall.

Keywords: Hepatocellular cancer; cirrhosis; liver failure; non-alcoholic fatty liver disease; surveillance.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Illustration of the number of patients required to be in surveillance to prevent one death each year. Individuals under surveillance are illustrated. Those without hepatocellular carcinoma (HCC) are shown in grey (n=390), those developing HCC are shown in green (n=9), and the individual whose death from HCC is prevented is shown in purple (n=1).
See this image and copyright information in PMC

References

    1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71. - PMC - PubMed
    1. Forner A. Llovet JM. Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55. - PubMed
    1. Ladep NG. Khan SA. Crossey MM, et al. Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations. World J Gastroenterol. 2014;20:1544–53. - PMC - PubMed
    1. Sheron N. Alcohol and liver disease in Europe – Simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol. 2016;64:957–67. - PubMed
    1. Younossi ZM. Koenig AB. Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed